Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates

Background/Objectives: Streptococcus pyogenes (Group A Streptococcus, GAS) remains a major human pathogen. This study aimed to determine the phenotypic profiles of macrolide resistance in S. pyogenes isolates from southeastern Turkey and to investigate underlying genotypic mechanisms using Oxford Nanopore sequencing. Methods: A total of 83 clinical isolates of S. pyogenes were collected between January 2024 and June 2025. Antimicrobial susceptibility was assessed by disk diffusion following EUCAST guidelines (Breakpoint Tables v15.0). Macrolide resistance phenotypes [inducible MLSB (iMLSB), constitutive MLSB (cMLSB), and M phenotype] were determined by the D-zone test. Whole-genome sequencing of erythromycin-resistant isolates was performed using Oxford Nanopore technology, and resistance determinants were analyzed with ResFinder pipeline. Results: All isolates were susceptible to penicillin. Six isolates (7.2%) exhibited erythromycin resistance: three iMLSB, two cMLSB, and one M phenotype. All three adult isolates were iMLSB, whereas the pediatric isolates comprised one M and two cMLSB phenotypes; given the small number of isolates, no conclusion on age-related differences can be drawn. Genotypic analysis revealed erm(A) in all iMLSB isolates, mef(A)/msr(D) in the M phenotype, and the absence of acquired macrolide resistance genes in cMLSB isolates. Co-occurrence of tetracycline resistance genes (tetM/O) was observed in four of the six isolates. Conclusions: Penicillin remains the cornerstone of GAS therapy; however, macrolide resistance persists through diverse mechanisms. The coexistence of erm(A)-mediated iMLSB, mef(A)/msr(D)-associated M phenotype, and unexplained cMLSB resistance highlights the need for routine D-testing and genomic surveillance. These findings emphasize the importance of integrating phenotypic and genotypic approaches to monitor resistance evolution in GAS.

Authors

Publication Details

Journal
Antibiotics
Published
2026-11-18
DOI
https://doi.org/10.3390/antibiotics15111148
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates

Ayla Behnejad Kazancik, Nida Özcan, Asuman Akar, Serkan Kaydaş
Antibiotics
Streptococcal Infections and Treatments
article

Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates

Ayla Behnejad Kazancik, Nida Özcan, Asuman Akar, Serkan Kaydaş
article en

Abstract

Background/Objectives: Streptococcus pyogenes (Group A Streptococcus, GAS) remains a major human pathogen. This study aimed to determine the phenotypic profiles of macrolide resistance in S. pyogenes isolates from southeastern Turkey and to investigate underlying genotypic mechanisms using Oxford Nanopore sequencing. Methods: A total of 83 clinical isolates of S. pyogenes were collected between January 2024 and June 2025. Antimicrobial susceptibility was assessed by disk diffusion following EUCAST guidelines (Breakpoint Tables v15.0). Macrolide resistance phenotypes [inducible MLSB (iMLSB), constitutive MLSB (cMLSB), and M phenotype] were determined by the D-zone test. Whole-genome sequencing of erythromycin-resistant isolates was performed using Oxford Nanopore technology, and resistance determinants were analyzed with ResFinder pipeline. Results: All isolates were susceptible to penicillin. Six isolates (7.2%) exhibited erythromycin resistance: three iMLSB, two cMLSB, and one M phenotype. All three adult isolates were iMLSB, whereas the pediatric isolates comprised one M and two cMLSB phenotypes; given the small number of isolates, no conclusion on age-related differences can be drawn. Genotypic analysis revealed erm(A) in all iMLSB isolates, mef(A)/msr(D) in the M phenotype, and the absence of acquired macrolide resistance genes in cMLSB isolates. Co-occurrence of tetracycline resistance genes (tetM/O) was observed in four of the six isolates. Conclusions: Penicillin remains the cornerstone of GAS therapy; however, macrolide resistance persists through diverse mechanisms. The coexistence of erm(A)-mediated iMLSB, mef(A)/msr(D)-associated M phenotype, and unexplained cMLSB resistance highlights the need for routine D-testing and genomic surveillance. These findings emphasize the importance of integrating phenotypic and genotypic approaches to monitor resistance evolution in GAS.

AntibioticsVol. 15(11)
Dicle Üniversitesi
Good health and well-being
Streptococcal Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon